LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,307,000 | -22.2% | 8,466,783 | 0.0% | 0.04% | -20.4% |
Q2 2022 | $2,967,000 | -48.5% | 8,466,783 | 0.0% | 0.05% | -41.9% |
Q1 2022 | $5,758,000 | -70.6% | 8,466,783 | 0.0% | 0.09% | -62.9% |
Q4 2021 | $19,558,000 | -49.6% | 8,466,783 | 0.0% | 0.25% | -41.1% |
Q3 2021 | $38,778,000 | +3.2% | 8,466,783 | 0.0% | 0.43% | +12.1% |
Q2 2021 | $37,593,000 | -39.0% | 8,466,783 | 0.0% | 0.38% | -34.0% |
Q1 2021 | $61,638,000 | -4.6% | 8,466,783 | 0.0% | 0.58% | +1.9% |
Q4 2020 | $64,602,000 | +10.0% | 8,466,783 | +30.9% | 0.56% | -23.4% |
Q3 2020 | $58,718,000 | +7.3% | 6,466,783 | 0.0% | 0.74% | -4.2% |
Q2 2020 | $54,709,000 | +71.3% | 6,466,783 | 0.0% | 0.77% | +43.4% |
Q1 2020 | $31,946,000 | -31.4% | 6,466,783 | 0.0% | 0.54% | -19.2% |
Q4 2019 | $46,561,000 | -33.4% | 6,466,783 | 0.0% | 0.66% | -49.8% |
Q3 2019 | $69,906,000 | -16.8% | 6,466,783 | 0.0% | 1.33% | +1.8% |
Q2 2019 | $84,068,000 | +31.6% | 6,466,783 | 0.0% | 1.30% | +31.6% |
Q1 2019 | $63,892,000 | -5.0% | 6,466,783 | 0.0% | 0.99% | -20.5% |
Q4 2018 | $67,255,000 | – | 6,466,783 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |